// App-Quantinova.ai

: Prevalence and Correlates of Echocardiographic Abnormalities in Type 2 Diabetes Insights From iCaReMe Global Registry

Researchers

Presenter

  • Mikhail N Kosiborod

Principal Investigators

  • Carolyn S Lam

  • Kamlesh Khunti

  • Hiddo Lambers Heerspink

  • Antonio Nicolucci

  • Shashank Joshi

  • Peter Fenici

  • Filip Surmont

  • Susana Goncalves

  • Hardik Vasnawala

  • Estefania Vazquez

  • Ahmed HADAOUI

Medical Centers

  • AstraZeneca, International, Buenos Aires, Argentina, Argentina

  • Center for Outcomes Research and Clinical Epidemiology, Coresearch, Pescara, Italy

  • ASTRAZENECA, Manziana, Italy

  • ASTRAZENECA, Shanghai, China, China

  • UNIVERSITY MEDICAL CENTER GRONINGEN, Groningen

  • AstraZeneca, Guadalajara, Mexico, Mexico

  • Joshi Clinic, Lilavati & Bhatia Hosp, Mumbai, India, India

  • ST LUKES HEALTH SYSTEM, Kansas City, MO

  • NATIONAL HEART CENTRE SINGAPORE, Singapore

  • Diabetes Rsch Cntr, Univ of Leicester, Leicester, UK, United Kingdom

Locations

  • India

  • Algeria

  • United Kingdom

  • United States

  • China

  • Netherlands

  • Italy

  • Mexico

  • Singapore

  • Argentina

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Cardiovascular (CVS)

  • Nephrology

  • Endocrine/metabolic Diseases (ME)

Disease

  • Chronic kidney disease

  • Type 2 diabetes mellitus

  • Renal disease

  • Congestive heart failure

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

  • Multinational

Phase

  • N/A

Study Id's

  • NCT03549754

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved